OliX Pharmaceuticals Inc banner
O

OliX Pharmaceuticals Inc
KOSDAQ:226950

Watchlist Manager
OliX Pharmaceuticals Inc
KOSDAQ:226950
Watchlist
Price: 203 000 KRW -1.93% Market Closed
Market Cap: ₩4.1T

Wall Street
Price Targets

Price Targets Summary
OliX Pharmaceuticals Inc

There are no price targets for OliX Pharmaceuticals Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
OliX Pharmaceuticals Inc Competitors:
Price Targets
EOLS
Evolus Inc
176% Upside
WINA
Winmark Corp
26% Upside
CSGP
CoStar Group Inc
70% Upside

Revenue
Forecast

57% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
60%
Average Beat
57% / Year
Past Growth
50% / Year
Estimated Growth
Estimates Accuracy
60%
Average Beat

For the last 7 years the compound annual growth rate for OliX Pharmaceuticals Inc's revenue is 57%. The projected CAGR for the next 3 years is 50%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
48%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
48%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OliX Pharmaceuticals Inc's stock price target?
Not Available

OliX Pharmaceuticals Inc doesn't have any price targets made by Wall Street professionals.

What is OliX Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
50%

For the last 7 years the compound annual growth rate for OliX Pharmaceuticals Inc's revenue is 57%. The projected CAGR for the next 3 years is 50%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett